title: LH and FSH secretion and responses to GnRH and TRH in patients with clinically functionless pituitary adenomas.
abstract: Serum concentrations of LH and FSH and their response to the separate administration of GnRH (100 micrograms i.v.) and TRH (200 micrograms i.v.) have been studied preoperatively in 12 patients with a clinically functionless pituitary adenoma, of whom nine (3F: 6M) were found to secrete gonadotrophins in vitro. In three patients with a gonadotrophin-secreting adenoma (GSA) the pulsatile release of LH and FSH was also assessed preoperatively. An elevated serum FSH was recorded in six of nine patients with a GSA, and was subnormal in one, whilst an elevated LH was recorded in only two and was subnormal in six. A doubling of LH occurred in only four of the nine patients after GnRH and in three of six after TRH. None of the three patients with a non-GSA was shown to have an aberrant response to GnRH or TRH. In patients with a GSA, pulsatile release of LH and FSH was usually asynchronous and neither hormone demonstrated any regular harmonic pattern. These data show that in patients with a GSA the serum FSH level is usually elevated but this is not invariable, and the LH may well be low. Pathological responses of LH are frequently found following the administration of either GnRH or TRH and these stimulation tests should be performed separately in patients presenting with a clinically 'non-functioning' pituitary tumour to assist in the preoperative diagnosis. The absence of normal LH and FSH pulsing also appears to be a feature of GS adenomas, and suggests that tumorous gonadotrophin secretion is not under physiological control by hypothalamic GnRH.
authors.affiliation: Department of Medicine, University of Newcastle on Tyne, UK.
authors.forename: M C
authors.initials: MC
authors.lastname: White
authors.forename: M
authors.initials: M
authors.lastname: Daniels
authors.forename: P
authors.initials: P
authors.lastname: Newland
authors.forename: C J
authors.initials: CJ
authors.lastname: Thompson
authors.forename: D
authors.initials: D
authors.lastname: Cook
authors.forename: J
authors.initials: J
authors.lastname: Dewar
authors.forename: R
authors.initials: R
authors.lastname: Perry
authors.forename: R
authors.initials: R
authors.lastname: Jewitt
authors.forename: D
authors.initials: D
authors.lastname: Mathias
authors.forename: A P
authors.initials: AP
authors.lastname: Murdoch
mesh_terms: D000236:Adenoma / Q000503:physiopathology*; D000328:Adult; D000368:Aged; D002478:Cells, Cultured; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D007986:Luteinizing Hormone / Q000097:blood / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010906:Pituitary Hormone-Releasing Hormones / Q000494:pharmacology*; D010911:Pituitary Neoplasms / Q000503:physiopathology*; D011863:Radioimmunoassay; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology*
chemical_list: D010906:Pituitary Hormone-Releasing Hormones; D013973:Thyrotropin-Releasing Hormone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone